We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$9.47B
AUM Growth
+$600M
Cap. Flow
+$450M
Cap. Flow %
4.75%
Top 10 Hldgs %
19.81%
Holding
2,316
New
178
Increased
1,104
Reduced
849
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 5.55%
2 Financials 4.7%
3 Healthcare 4.16%
4 Industrials 3.45%
5 Consumer Discretionary 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIS
2151
DELISTED
Orchids Paper Products, Inc.
TIS
$51K ﹤0.01%
12,835
-2,744
-18% -$15.6K
TOO
2152
DELISTED
Teekay Offshore Partners L.P.
TOO
$50K ﹤0.01%
+18,900
New +$50.2K
CFBK icon
2153
CF Bankshares
CFBK
$232M
$48K ﹤0.01%
3,636
HL icon
2154
Hecla Mining
HL
$11.8B
$47K ﹤0.01%
13,415
+1,209
+10% +$4.6K
PLM
2155
DELISTED
PolyMet Mining Corp.
PLM
$46K ﹤0.01%
4,609
WPRT
2156
Westport Fuel Systems
WPRT
$35.7M
$44K ﹤0.01%
1,730
-152
-8% -$3.83K
TLPH icon
2157
Talphera
TLPH
$73.2M
$43K ﹤0.01%
634
-100
-14% -$5.94K
INO icon
2158
Inovio Pharmaceuticals
INO
$76.1M
$42K ﹤0.01%
900
-83
-8% -$4.58K
PLUG icon
2159
Plug Power
PLUG
$2.94B
$42K ﹤0.01%
20,821
+4,970
+31% +$9.66K
VIVS
2160
VivoSim Labs
VIVS
$1.27M
$42K ﹤0.01%
124
-5
-4% -$1.65K
INFI
2161
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$42K ﹤0.01%
+22,245
New +$44.9K
JE
2162
DELISTED
Just Energy Group Inc
JE
$42K ﹤0.01%
356
-336
-49% -$44K
PDLI
2163
DELISTED
PDL BioPharma, Inc.
PDLI
$41K ﹤0.01%
17,477
-10,546
-38% -$29.4K
SDR
2164
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$41K ﹤0.01%
22,514
+10,579
+89% +$14.5K
XXII
2165
22nd Century Group
XXII
$1.5M
0
SDLP
2166
DELISTED
SEADRILL PARTNERS LLC
SDLP
$37K ﹤0.01%
1,065
AMRN
2167
Amarin Corp
AMRN
$298M
$36K ﹤0.01%
586
-307
-34% -$19K
GERN icon
2168
Geron
GERN
$949M
$36K ﹤0.01%
+10,535
New +$40.2K
MNKD icon
2169
MannKind Corp
MNKD
$1.26B
$36K ﹤0.01%
18,694
-800
-4% -$1.5K
APRN
2170
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$35K ﹤0.01%
+58
New +$27.4K
EXK
2171
Endeavour Silver
EXK
$3.03B
$31K ﹤0.01%
10,010
QMCO icon
2172
Quantum Corp
QMCO
$464M
$31K ﹤0.01%
+710
New +$47.6K
TURN
2173
DELISTED
180 Degree Capital
TURN
$30K ﹤0.01%
4,308
JCP
2174
DELISTED
J.C. Penney Company, Inc.
JCP
$28K ﹤0.01%
+11,940
New +$33.7K
NAVB
2175
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$27K ﹤0.01%
5,905
+86
+1% +$450

Similar funds

Cambridge Investment Research Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Cambridge Investment Research Advisors held 2,316 positions worth $9.47B, up 6.8% from $8.87B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $450M of net new capital in Q2 2018, opening 178 new positions and adding to 1,104 existing holdings. Its largest new stake was Invesco S&P 500 Quality ETF: 220,002 shares worth $6.6M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was First Trust Dorsey Wright Focus 5 ETF, an estimated $23.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2018 buy was Invesco S&P 500 Quality ETF: 220,002 shares worth $6.6M.
  • Cambridge Investment Research Advisors added most to iShares S&P 500 Growth ETF in Q2 2018, an estimated $39.8M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2018 reduction was First Trust Dorsey Wright Focus 5 ETF, cutting an estimated $23.2M.
  • Cambridge Investment Research Advisors fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $8.51M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $9.47B portfolio in Q2 2018.
  • Cambridge Investment Research Advisors opened 178 new positions and closed 119 in Q2 2018.
  • Cambridge Investment Research Advisors's portfolio value rose 6.8% quarter-over-quarter to $9.47B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.